Annual SG&A
$431.78 M
+$55.10 M+14.63%
31 March 2024
Summary:
Haemonetics annual selling, general & administrative expenses is currently $431.78 million, with the most recent change of +$55.10 million (+14.63%) on 31 March 2024. During the last 3 years, it has risen by +$156.56 million (+56.89%). HAE annual SG&A is now at all-time high.HAE Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$106.95 M
-$1.30 M-1.20%
28 September 2024
Summary:
Haemonetics quarterly selling, general & administrative expenses is currently $106.95 million, with the most recent change of -$1.30 million (-1.20%) on 28 September 2024. Over the past year, it has dropped by -$8.37 million (-7.26%). HAE quarterly SG&A is now -12.11% below its all-time high of $121.68 million, reached on 30 March 2024.HAE Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$1.46 B
+$59.64 M+4.27%
28 September 2024
Summary:
Haemonetics TTM selling, general & administrative expenses is currently $1.46 billion, with the most recent change of +$59.64 million (+4.27%) on 28 September 2024. Over the past year, it has increased by +$1.05 billion (+262.82%). HAE TTM SG&A is now -13.22% below its all-time high of $456.96 million, reached on 29 June 2024.HAE TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +14.6% | -7.3% | +262.8% |
3 y3 years | +56.9% | +32.5% | +339.2% |
5 y5 years | +57.9% | +37.3% | +422.5% |
HAE Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +56.9% | -12.1% | +41.1% | at high | +123.6% |
5 y | 5 years | at high | +57.9% | -12.1% | +102.4% | at high | +350.6% |
alltime | all time | at high | +607.8% | -12.1% | +1427.8% | -13.2% | +3325.3% |
Haemonetics Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $106.95 M(-1.2%) | $448.59 M(-1.8%) |
June 2024 | - | $108.25 M(-11.0%) | $456.96 M(+3.3%) |
Mar 2024 | $431.78 M(+14.6%) | - | - |
Mar 2024 | - | $121.68 M(+8.9%) | $442.20 M(+5.7%) |
Dec 2023 | - | $111.71 M(-3.1%) | $418.28 M(+4.2%) |
Sept 2023 | - | $115.32 M(+23.4%) | $401.22 M(+6.2%) |
June 2023 | - | $93.48 M(-4.4%) | $377.93 M(+0.3%) |
Mar 2023 | $376.68 M(+10.7%) | $97.76 M(+3.3%) | $376.68 M(+1.4%) |
Dec 2022 | - | $94.66 M(+2.9%) | $371.33 M(+3.9%) |
Sept 2022 | - | $92.03 M(-0.2%) | $357.40 M(+4.8%) |
June 2022 | - | $92.23 M(-0.2%) | $341.15 M(+0.3%) |
Mar 2022 | $340.14 M(+23.6%) | $92.42 M(+14.5%) | $340.14 M(+2.6%) |
Dec 2021 | - | $80.73 M(+6.5%) | $331.43 M(+4.8%) |
Sept 2021 | - | $75.78 M(-16.9%) | $316.35 M(+4.0%) |
June 2021 | - | $91.22 M(+9.0%) | $304.14 M(+10.5%) |
Mar 2021 | $275.22 M(-2.4%) | $83.71 M(+27.5%) | $275.23 M(+12.6%) |
Dec 2020 | - | $65.64 M(+3.3%) | $244.34 M(-4.9%) |
Sept 2020 | - | $63.57 M(+2.0%) | $256.97 M(-5.3%) |
June 2020 | - | $62.30 M(+17.9%) | $271.32 M(-3.8%) |
Mar 2020 | $282.02 M(+3.1%) | $52.83 M(-32.5%) | $282.02 M(-0.3%) |
Dec 2019 | - | $78.27 M(+0.4%) | $282.99 M(+1.6%) |
Sept 2019 | - | $77.92 M(+6.7%) | $278.60 M(+0.2%) |
June 2019 | - | $73.00 M(+35.7%) | $277.93 M(+1.6%) |
Mar 2019 | $273.47 M(-13.6%) | $53.80 M(-27.2%) | $273.47 M(-8.4%) |
Dec 2018 | - | $73.88 M(-4.4%) | $298.69 M(-7.4%) |
Sept 2018 | - | $77.25 M(+12.7%) | $322.67 M(+1.4%) |
June 2018 | - | $68.55 M(-13.3%) | $318.21 M(+0.5%) |
Mar 2018 | $316.52 M(+4.9%) | $79.02 M(-19.2%) | $316.52 M(+2.4%) |
Dec 2017 | - | $97.86 M(+34.4%) | $309.20 M(+9.4%) |
Sept 2017 | - | $72.78 M(+8.9%) | $282.75 M(+0.6%) |
June 2017 | - | $66.86 M(-6.8%) | $281.09 M(-6.8%) |
Mar 2017 | $301.73 M(-4.9%) | $71.70 M(+0.4%) | $301.73 M(-1.5%) |
Dec 2016 | - | $71.41 M(+0.4%) | $306.30 M(-2.4%) |
Sept 2016 | - | $71.12 M(-18.7%) | $313.83 M(-1.1%) |
June 2016 | - | $87.50 M(+14.7%) | $317.28 M(-0.0%) |
Mar 2016 | $317.22 M(-5.9%) | $76.28 M(-3.4%) | $317.39 M(-0.5%) |
Dec 2015 | - | $78.94 M(+5.9%) | $318.90 M(-1.1%) |
Sept 2015 | - | $74.56 M(-14.9%) | $322.47 M(-3.1%) |
June 2015 | - | $87.61 M(+12.6%) | $332.68 M(-1.5%) |
Mar 2015 | $337.17 M(-7.9%) | $77.78 M(-5.7%) | $337.63 M(-3.0%) |
Dec 2014 | - | $82.51 M(-2.7%) | $347.94 M(-2.0%) |
Sept 2014 | - | $84.77 M(-8.4%) | $354.99 M(+0.9%) |
June 2014 | - | $92.56 M(+5.1%) | $351.73 M(-3.9%) |
Mar 2014 | $365.98 M(+13.3%) | $88.10 M(-1.6%) | $365.98 M(+0.1%) |
Dec 2013 | - | $89.56 M(+9.9%) | $365.49 M(+0.8%) |
Sept 2013 | - | $81.51 M(-23.7%) | $362.71 M(+0.1%) |
June 2013 | - | $106.81 M(+21.9%) | $362.24 M(+12.1%) |
Mar 2013 | $323.05 M(+31.7%) | $87.61 M(+1.0%) | $323.05 M(+7.5%) |
Dec 2012 | - | $86.78 M(+7.1%) | $300.48 M(+9.2%) |
Sept 2012 | - | $81.03 M(+19.8%) | $275.07 M(+7.2%) |
June 2012 | - | $67.63 M(+4.0%) | $256.65 M(+4.6%) |
Mar 2012 | $245.26 M(+14.7%) | $65.04 M(+6.0%) | $245.26 M(+6.6%) |
Dec 2011 | - | $61.38 M(-2.0%) | $230.04 M(+2.0%) |
Sept 2011 | - | $62.61 M(+11.3%) | $225.60 M(+4.6%) |
June 2011 | - | $56.23 M(+12.9%) | $215.78 M(+0.9%) |
Mar 2011 | $213.90 M(-0.3%) | $49.82 M(-12.5%) | $213.90 M(-6.2%) |
Dec 2010 | - | $56.94 M(+7.9%) | $228.10 M(+1.7%) |
Sept 2010 | - | $52.79 M(-2.9%) | $224.32 M(+2.4%) |
June 2010 | - | $54.35 M(-15.1%) | $219.00 M(+2.1%) |
Mar 2010 | $214.48 M(+7.9%) | $64.02 M(+20.5%) | $214.48 M(+3.4%) |
Dec 2009 | - | $53.15 M(+12.0%) | $207.52 M(+2.6%) |
Sept 2009 | - | $47.47 M(-4.8%) | $202.33 M(+0.8%) |
June 2009 | - | $49.84 M(-12.7%) | $200.72 M(+1.0%) |
Mar 2009 | $198.74 M(+21.8%) | $57.06 M(+19.0%) | $198.74 M(+7.2%) |
Dec 2008 | - | $47.97 M(+4.6%) | $185.38 M(+3.7%) |
Sept 2008 | - | $45.86 M(-4.2%) | $178.85 M(+4.3%) |
June 2008 | - | $47.86 M(+9.5%) | $171.53 M(+5.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2008 | $163.12 M(+19.0%) | $43.70 M(+5.5%) | $163.12 M(+7.9%) |
Dec 2007 | - | $41.43 M(+7.5%) | $151.23 M(+5.5%) |
Sept 2007 | - | $38.55 M(-2.3%) | $143.41 M(+2.7%) |
June 2007 | - | $39.44 M(+24.0%) | $139.60 M(+1.8%) |
Mar 2007 | $137.07 M(+13.0%) | $31.82 M(-5.3%) | $137.07 M(+1.7%) |
Dec 2006 | - | $33.61 M(-3.3%) | $134.77 M(+1.8%) |
Sept 2006 | - | $34.74 M(-5.9%) | $132.41 M(+3.6%) |
June 2006 | - | $36.91 M(+25.1%) | $127.77 M(+5.3%) |
Mar 2006 | $121.35 M(+2.8%) | $29.51 M(-5.6%) | $121.35 M(-2.5%) |
Dec 2005 | - | $31.25 M(+3.8%) | $124.51 M(+1.1%) |
Sept 2005 | - | $30.10 M(-1.3%) | $123.16 M(+2.3%) |
June 2005 | - | $30.49 M(-6.7%) | $120.44 M(+2.0%) |
Mar 2005 | $118.04 M(+8.4%) | $32.67 M(+9.3%) | $118.04 M(+2.6%) |
Dec 2004 | - | $29.90 M(+9.2%) | $115.01 M(+4.5%) |
Sept 2004 | - | $27.39 M(-2.5%) | $110.06 M(-0.4%) |
June 2004 | - | $28.08 M(-5.3%) | $110.53 M(+1.5%) |
Mar 2004 | $108.84 M(+11.4%) | $29.64 M(+18.8%) | $108.84 M(+4.2%) |
Dec 2003 | - | $24.95 M(-10.4%) | $104.45 M(+0.4%) |
Sept 2003 | - | $27.85 M(+5.5%) | $103.99 M(+3.9%) |
June 2003 | - | $26.40 M(+4.6%) | $100.09 M(+2.4%) |
Mar 2003 | $97.70 M(+9.9%) | $25.25 M(+3.1%) | $97.70 M(+3.7%) |
Dec 2002 | - | $24.49 M(+2.2%) | $94.22 M(+1.3%) |
Sept 2002 | - | $23.95 M(-0.3%) | $93.02 M(+2.3%) |
June 2002 | - | $24.02 M(+10.3%) | $90.92 M(+2.3%) |
Mar 2002 | $88.87 M(+2.5%) | $21.77 M(-6.5%) | $88.92 M(-0.4%) |
Dec 2001 | - | $23.28 M(+6.5%) | $89.27 M(+0.5%) |
Sept 2001 | - | $21.86 M(-0.7%) | $88.81 M(+1.1%) |
June 2001 | - | $22.01 M(-0.5%) | $87.83 M(+1.2%) |
Mar 2001 | $86.73 M(+4.6%) | $22.12 M(-3.1%) | $86.80 M(+1.2%) |
Dec 2000 | - | $22.82 M(+9.4%) | $85.78 M(+2.8%) |
Sept 2000 | - | $20.87 M(-0.5%) | $83.45 M(+0.4%) |
June 2000 | - | $20.98 M(-0.5%) | $83.08 M(+0.3%) |
Mar 2000 | $82.89 M(-4.6%) | $21.09 M(+2.9%) | $82.80 M(-0.3%) |
Dec 1999 | - | $20.50 M(0.0%) | $83.08 M(+0.5%) |
Sept 1999 | - | $20.50 M(-1.0%) | $82.68 M(0.0%) |
June 1999 | - | $20.70 M(-3.2%) | $82.68 M(-4.8%) |
Mar 1999 | $86.88 M(-0.0%) | $21.38 M(+6.4%) | $86.88 M(-2.8%) |
Dec 1998 | - | $20.10 M(-2.0%) | $89.40 M(-0.9%) |
Sept 1998 | - | $20.50 M(-17.7%) | $90.20 M(-1.0%) |
June 1998 | - | $24.90 M(+4.2%) | $91.10 M(+2.7%) |
Mar 1998 | $86.90 M(-1.4%) | $23.90 M(+14.4%) | $88.70 M(+5.2%) |
Dec 1997 | - | $20.90 M(-2.3%) | $84.30 M(-2.5%) |
Sept 1997 | - | $21.40 M(-4.9%) | $86.50 M(-1.0%) |
June 1997 | - | $22.50 M(+15.4%) | $87.40 M(-0.7%) |
Mar 1997 | $88.10 M(+7.7%) | $19.50 M(-15.6%) | $88.00 M(-2.3%) |
Dec 1996 | - | $23.10 M(+3.6%) | $90.10 M(+3.1%) |
Sept 1996 | - | $22.30 M(-3.5%) | $87.40 M(+2.3%) |
June 1996 | - | $23.10 M(+6.9%) | $85.40 M(+4.4%) |
Mar 1996 | $81.80 M(+8.1%) | $21.60 M(+5.9%) | $81.80 M(+3.0%) |
Dec 1995 | - | $20.40 M(+0.5%) | $79.40 M(+1.8%) |
Sept 1995 | - | $20.30 M(+4.1%) | $78.00 M(+2.1%) |
June 1995 | - | $19.50 M(+1.6%) | $76.40 M(+0.9%) |
Mar 1995 | $75.70 M(-0.3%) | $19.20 M(+1.1%) | $75.70 M(+19.2%) |
Dec 1994 | - | $19.00 M(+1.6%) | $63.50 M(-6.2%) |
Sept 1994 | - | $18.70 M(-0.5%) | $67.70 M(-6.9%) |
June 1994 | - | $18.80 M(+168.6%) | $72.70 M(-4.2%) |
Mar 1994 | $75.90 M(-1.7%) | $7.00 M(-69.8%) | $75.90 M(-15.3%) |
Dec 1993 | - | $23.20 M(-2.1%) | $89.60 M(+3.5%) |
Sept 1993 | - | $23.70 M(+7.7%) | $86.60 M(+6.1%) |
June 1993 | - | $22.00 M(+6.3%) | $81.60 M(+5.8%) |
Mar 1993 | $77.20 M(+26.6%) | $20.70 M(+2.5%) | $77.10 M(+5.3%) |
Dec 1992 | - | $20.20 M(+8.0%) | $73.20 M(+5.9%) |
Sept 1992 | - | $18.70 M(+6.9%) | $69.10 M(+6.5%) |
June 1992 | - | $17.50 M(+4.2%) | $64.90 M(+6.4%) |
Mar 1992 | $61.00 M | $16.80 M(+4.3%) | $61.00 M(+38.0%) |
Dec 1991 | - | $16.10 M(+11.0%) | $44.20 M(+57.3%) |
Sept 1991 | - | $14.50 M(+6.6%) | $28.10 M(+106.6%) |
June 1991 | - | $13.60 M | $13.60 M |
FAQ
- What is Haemonetics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Haemonetics?
- What is Haemonetics annual SG&A year-on-year change?
- What is Haemonetics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Haemonetics?
- What is Haemonetics quarterly SG&A year-on-year change?
- What is Haemonetics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Haemonetics?
- What is Haemonetics TTM SG&A year-on-year change?
What is Haemonetics annual selling, general & administrative expenses?
The current annual SG&A of HAE is $431.78 M
What is the all time high annual SG&A for Haemonetics?
Haemonetics all-time high annual selling, general & administrative expenses is $431.78 M
What is Haemonetics annual SG&A year-on-year change?
Over the past year, HAE annual selling, general & administrative expenses has changed by +$55.10 M (+14.63%)
What is Haemonetics quarterly selling, general & administrative expenses?
The current quarterly SG&A of HAE is $106.95 M
What is the all time high quarterly SG&A for Haemonetics?
Haemonetics all-time high quarterly selling, general & administrative expenses is $121.68 M
What is Haemonetics quarterly SG&A year-on-year change?
Over the past year, HAE quarterly selling, general & administrative expenses has changed by -$8.37 M (-7.26%)
What is Haemonetics TTM selling, general & administrative expenses?
The current TTM SG&A of HAE is $1.46 B
What is the all time high TTM SG&A for Haemonetics?
Haemonetics all-time high TTM selling, general & administrative expenses is $456.96 M
What is Haemonetics TTM SG&A year-on-year change?
Over the past year, HAE TTM selling, general & administrative expenses has changed by +$1.05 B (+262.82%)